|
| | HB2874 Enrolled | | LRB104 09796 RLC 19862 b |
|
|
| 1 | | AN ACT concerning criminal law. |
| 2 | | Be it enacted by the People of the State of Illinois, |
| 3 | | represented in the General Assembly: |
| 4 | | Section 5. The Illinois Controlled Substances Act is |
| 5 | | amended by changing Section 216 as follows: |
| 6 | | (720 ILCS 570/216) |
| 7 | | Sec. 216. Ephedrine. |
| 8 | | (a) The following drug products containing ephedrine, its |
| 9 | | salts, optical isomers and salts of optical isomers shall be |
| 10 | | exempt from the application of Sections 312 and 313 of this Act |
| 11 | | if they: (i) may lawfully be sold over-the-counter without a |
| 12 | | prescription under the Federal Food, Drug, and Cosmetic Act; |
| 13 | | (ii) are labeled and marketed in a manner consistent with |
| 14 | | Section 341.76 of Title 21 of the Code of Federal Regulations; |
| 15 | | (iii) are manufactured and distributed for legitimate |
| 16 | | medicinal use in a manner that reduces or eliminates the |
| 17 | | likelihood of abuse; and (iv) are not marketed, advertised, or |
| 18 | | labeled for the indications of stimulation, mental alertness, |
| 19 | | weight loss, muscle enhancement, appetite control, or energy: |
| 20 | | (1) Solid oral dosage forms, including soft gelatin |
| 21 | | caplets, which are formulated pursuant to 21 CFR 341 or |
| 22 | | its successor, and packaged in blister packs of not more |
| 23 | | than 2 tablets per blister. |
|
| | HB2874 Enrolled | - 2 - | LRB104 09796 RLC 19862 b |
|
|
| 1 | | (2) Anorectal preparations containing not more than 5% |
| 2 | | ephedrine. |
| 3 | | (b) The marketing, advertising, or labeling of any product |
| 4 | | containing ephedrine, a salt of ephedrine, an optical isomer |
| 5 | | of ephedrine, or a salt of an optical isomer of ephedrine, for |
| 6 | | the indications of stimulation, mental alertness, weight loss, |
| 7 | | appetite control, or energy, is prohibited. In determining |
| 8 | | compliance with this requirement the Department may consider |
| 9 | | the following factors: |
| 10 | | (1) The packaging of the drug product; |
| 11 | | (2) The name and labeling of the product; |
| 12 | | (3) The manner of distribution, advertising, and |
| 13 | | promotion of the product; |
| 14 | | (4) Verbal representations made concerning the |
| 15 | | product; |
| 16 | | (5) The duration, scope, and significance of misuse of |
| 17 | | the particular product. |
| 18 | | (c) A violation of this Section is a Class A misdemeanor. A |
| 19 | | second or subsequent violation of this Section is a Class 4 |
| 20 | | felony. |
| 21 | | (d) This Section does not apply to dietary supplements, |
| 22 | | herbs, or other natural products, including concentrates or |
| 23 | | extracts, which: |
| 24 | | (1) are not otherwise prohibited by law; and |
| 25 | | (2) may contain naturally occurring ephedrine, |
| 26 | | ephedrine alkaloids, or pseudoephedrine, or their salts, |
|
| | HB2874 Enrolled | - 3 - | LRB104 09796 RLC 19862 b |
|
|
| 1 | | isomers, or salts of isomers, or a combination of these |
| 2 | | substances, that: |
| 3 | | (i) are contained in a matrix of organic material; |
| 4 | | and |
| 5 | | (ii) do not exceed 15% of the total weight of the |
| 6 | | natural product. |
| 7 | | (e) Nothing in this Section limits the scope or terms of |
| 8 | | the Methamphetamine Precursor Control Act. |
| 9 | | (f) This Section does not apply to the sale of any product |
| 10 | | dispensed or delivered by a practitioner or pharmacy according |
| 11 | | to a prescription issued by a prescriber authorized by this |
| 12 | | State or another state for a valid medical purpose and in the |
| 13 | | course of professional practice. |
| 14 | | (Source: P.A. 103-881, eff. 1-1-25.) |